Search

Your search keyword '"de Wreede, Liesbeth C."' showing total 37 results
Start Over "de Wreede, Liesbeth C." Journal blood
37 results on '"de Wreede, Liesbeth C."'

1. Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

Author

Scheid, Christof, Eikema, Diderik-Jan, van Gelder, Michel, Salmenniemi, Urpu, Maertens, Johan, Passweg, Jakob, Blaise, Didier, Byrne, Jennifer L., Kröger, Nicolaus, Sockel, Katja, Chevallier, Patrice, Bourhis, Jean Henri, Cornelissen, Jan J., Sengeloev, Henrik, Finke, Jürgen, Snowden, John A., Gedde-Dahl, Tobias, Cornillon, Jérôme, Schanz, Urs, Patel, Amit, Koster, Linda, de Wreede, Liesbeth C., Hayden, Patrick, Raj, Kavita, Drozd-Sokolowska, Joanna, Gurnari, Carmelo, Onida, Francesco, McLornan, Donal P., Robin, Marie, and Yakoub-Agha, Ibrahim

Published
2024
Full Text
View/download PDF

2. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis

Author

Robin, Marie, de Wreede, Liesbeth C., Padron, Eric, Bakunina, Katerina, Fenaux, Pierre, Koster, Linda, Nazha, Aziz, Beelen, Dietrich W., Rampal, Raajit K., Sockel, Katja, Komrokji, Rami S., Gagelmann, Nico, Eikema, Dirk-Jan, Radujkovic, Aleksandar, Finke, Jürgen, Potter, Victoria, Killick, Sally B., Legrand, Faezeh, Solary, Eric, Broom, Angus, Garcia-Manero, Guillermo, Rizzoli, Vittorio, Hayden, Patrick, Patnaik, Mrinal M., Onida, Francesco, Yakoub-Agha, Ibrahim, and Itzykson, Raphael

Published
2022
Full Text
View/download PDF

3. Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Author

Robin, Marie, primary, Gras, Luuk, additional, Gagelmann, Nico, additional, Koster, Linda, additional, Peffault de Latour, Régis, additional, Van Gorkom, Gwendolyn, additional, Ganser, Arnold, additional, Itälä-Remes, Maija, additional, Zuckerman, Tsila, additional, Beguin, Yves, additional, Schaap, Nicolaas, additional, Drozd-Sokolowska, Joanna, additional, Raj, Kavita, additional, Hayden, Patrick J, additional, de Wreede, Liesbeth C., additional, Czerw, Tomasz, additional, Hernandez Boluda, Juan Carlos, additional, Kröger, Nicolaus, additional, Yakoub-agha, Ibrahim, additional, and McLornan, Donal P., additional

Published
2022
Full Text
View/download PDF

4. The HOVON 100 Study in Adult Acute Lymphoblastic Leukemia Re-Analysed By Multi-State Modeling: Benefits and Risks of Clofarabine

Author

Hermans, Sjoerd J.F., primary, Norden, Yvette, additional, Versluis, Jurjen, additional, Rijneveld, Anita W., additional, De Weerdt, Okke, additional, Biemond, Bart J., additional, van de Loosdrecht, Arjan A., additional, Van der Wagen, Lotte E., additional, Bellido, Mar, additional, Van Gelder, Michel, additional, Van der Velden, Walter J.F.M., additional, Selleslag, Dominik, additional, van Lammeren, Danielle, additional, van der Velden, Vincent H.J., additional, de Wreede, Liesbeth C., additional, Postmus, Douwe, additional, Pignatti, Francesco, additional, and Cornelissen, Jan J., additional

Published
2022
Full Text
View/download PDF

5. Gvhd Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the Cmwp of the EBMT

Author

Luft, Thomas, primary, Gras, Luuk, additional, Kostner, Linda, additional, Kröger, Nicolaus, additional, Schroeder, Thomas, additional, Platzbecker, Uwe, additional, Schetelig, Johannes, additional, Peffault de Latour, Régis, additional, Stelljes, Matthias, additional, Sengeloev, Henrik, additional, Ganser, Arnold, additional, Blau, Igor Wolfgang, additional, Dreger, Peter, additional, Yakoub-Agha, Ibrahim, additional, Maertens, Johan, additional, Salmenniemi, Urpu, additional, Bethge, Wolfgang, additional, Mielke, Stephan, additional, Kobbe, Guido, additional, Pouli, Anastasia, additional, de Wreede, Liesbeth C., additional, Raj, Kavita, additional, Drozd-Sokolowska, Joanna, additional, McLornan, Donal P., additional, and Robin, Marie, additional

Published
2022
Full Text
View/download PDF

6. Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Author

Von Dem Borne, Peter A., primary, Kemps-Mols, Berit M., additional, de Wreede, Liesbeth C., additional, van Beek, Adriaan A., additional, Snijders, Tjeerd J.F., additional, van Lammeren, Danielle, additional, Tijmensen, Janneke, additional, Sijs-Szabo, Aniko, additional, Nering Bögel, Theo L., additional, Oudshoorn, Mirjam A., additional, Halkes, Constantijn J.M., additional, van Balen, Peter, additional, Marijt, Erik W.A.F., additional, Tjon, Jennifer M.L., additional, Vermaat, Joost S.P., additional, and Veelken, Hendrik, additional

Published
2022
Full Text
View/download PDF

7. HLA Class I Mismatches Reduce Survival after HCT in the Ptcy Era: A Study By the EBMT Cellular Therapy and Immunobiology Working Party

Author

Arrieta-Bolanos, Esteban, Bonneville, Edouard F., Robin, Marie, Gedde-Dahl, Tobias, Salmenniemi, Urpu, Kröger, Nicolaus, Yakoub-Agha, Ibrahim, Crawley, Charles, Choi, Goda, Broers, Annoek E. C., Forcade, Edouard, Carre, Martin, Poiré, Xavier, Huynh, Anne, Reményi, Péter, Lenhoff, Stig, Ciceri, Fabio, Tholouli, Eleni, Schröder, Thomas, Deconinck, Eric, Carlson, Kristina Elisabet, de Wreede, Liesbeth C., Hoogenboom, Jorinde D., Malard, Florent, Ruggeri, Annalisa, and Fleischhauer, Katharina

Published
2023
Full Text
View/download PDF

8. Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in Europe between 1995-2018: An EBMT Retrospective Analysis

Author

McLornan, Donal P., primary, Eikema, Dirk-Jan, additional, Kröger, Nicolaus, additional, Koster, Linda, additional, Czerw, Tomasz, additional, Beelen, Dietrich W., additional, Angelucci, Emanuele, additional, Robin, Marie, additional, Bornhaeuser, Martin, additional, Passweg, Jakob, additional, McQuaker, Grant, additional, Vitek, Antonin, additional, Finke, Jürgen, additional, Blau, Igor W, additional, Niittyvuopio, Riitta, additional, Platzbecker, Uwe, additional, Cornelissen, Jan J., additional, Chevallier, Patrice, additional, Srour, Micha, additional, Stamatovic, Dragana, additional, Martínez-Lopez, Joaquín, additional, de Wreede, Liesbeth C., additional, Hayden, Patrick J, additional, Hernandez Boluda, Juan Carlos, additional, and Yakoub-Agha, Ibrahim, additional

Published
2020
Full Text
View/download PDF

9. Daratumumab after Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Safety and Efficacy. a Retrospective Study from the Cmwp EBMT

Author

Vincent, Laure, primary, Gras, Luuk, additional, Ceballos, Patrice, additional, Finke, Jürgen, additional, Passweg, Jakob, additional, Robin, Marie, additional, Rosinol, Laura, additional, Minnema, Monique C., additional, Teipel, Raphael, additional, Van Deosum, JA, additional, Haenel, Mathias, additional, Lenain, Pascal, additional, Forcade, Edouard, additional, Koenecke, Christian, additional, Ducastelle, Sophie, additional, Sanz, Jaime, additional, Schroyens, Wilfried, additional, Zuckerman, Tsila, additional, Ladetto, Marco, additional, Koster, Linda, additional, de Wreede, Liesbeth C., additional, Hayden, Patrick J, additional, Schönland, Stefan, additional, Yakoub-Agha, Ibrahim, additional, and Beksac, Meral, additional

Published
2020
Full Text
View/download PDF

10. Does a Change in IPSS-R between Diagnosis and Transplant Have an Impact on Transplant Outcome in Patients with MDS? a Retrospective Analysis from the EBMT Chronic Malignancies Working Party

Author

Scheid, Christof, primary, Eikema, Dirk-Jan, additional, Niittyvuopio, Riitta, additional, Maertens, Johan, additional, Passweg, Jakob, additional, Blaise, Didier, additional, Byrne, Jennifer, additional, Kröger, Nicolaus, additional, Bornhäuser, Martin, additional, Chevallier, Patrice, additional, Bourhis, Jean-Henri, additional, Cornelissen, Jan J., additional, Sengeloev, Henrik, additional, Finke, Jürgen, additional, Snowden, John A, additional, Gedde-Dahl, Tobias, additional, Guyotat, Denis, additional, Schanz, Urs, additional, Patel, Amit, additional, Koster, Linda, additional, de Wreede, Liesbeth C., additional, Hayden, Patrick J, additional, Onida, Francesco, additional, Robin, Marie, additional, and Yakoub-Agha, Ibrahim, additional

Published
2020
Full Text
View/download PDF

11. External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails

Author

Schetelig, Johannes, primary, Baldauf, Henning, primary, Heidenreich, Falk, primary, Massalski, Carolin, primary, Frank, Sandra, primary, Sauter, Jürgen, primary, Stelljes, Matthias, primary, Ayuk, Francis Ayuketang, primary, Bethge, Wolfgang A., primary, Bug, Gesine, primary, Klein, Stefan, primary, Wendler, Sarah, primary, Lange, Vinzenz, primary, de Wreede, Liesbeth C., primary, Fürst, Daniel, primary, Kobbe, Guido, primary, Ottinger, Hellmut D., primary, Beelen, Dietrich W., primary, Mytilineos, Joannis, primary, Fleischhauer, Katharina, primary, Schmidt, Alexander H., primary, and Bornhäuser, Martin, primary

Published
2020
Full Text
View/download PDF

12. Autologous and Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome: A Large Series from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Author

Tournilhac, Olivier, primary, Guièze, Romain, additional, Eikema, Dirk-Jan, additional, Zinger, Nienke, additional, Sengeloev, Henrik, additional, Passweg, Jakob R., additional, Nielsen, Bendt, additional, Poire, Xavier, additional, Byrne, Jenny, additional, Gramatzki, Martin, additional, Finke, Jürgen, additional, Cornelissen, Jan J, additional, Blaise, D, additional, Nikolousis, Emmanouil, additional, Chevallier, Patrice, additional, Van Gorkom, Gwendolyn, additional, Ringhoffer, Mark, additional, Mordini, Nicola, additional, de Wreede, Liesbeth C., additional, Hayden, Patrick John, additional, van Gelder, Michel, additional, and Yakoub-Agha, Ibrahim, additional

Published
2019
Full Text
View/download PDF

13. Timing for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myelomonocytic Leukemia (CMML): A Joint Study from the International MDS/MPN Working Group and the Chronic Malignancies Working Party of the EBMT

Author

Robin, Marie, primary, de Wreede, Liesbeth C., additional, Padron, Eric, additional, Wang, Junfeng, additional, Hazelaar, Sheree, additional, Beelen, Dietrich W., additional, Fenaux, Pierre, additional, Bornhäuser, Martin, additional, Kroeger, Nicolaus, additional, Nazha, Aziz, additional, Radujkovic, Aleksandar, additional, Rampal, Raajit K., additional, Finke, Jürgen, additional, Komrokji, Rami S., additional, Potter, Victoria, additional, Killick, Sally, additional, Blaise, Didier, additional, Solary, Eric, additional, Broom, Angus, additional, Garcia-Manero, Guillermo, additional, Rizzoli, Vittorio, additional, Patnaik, Mrinal M, additional, Onida, Francesco, additional, Yakoub-Agha, Ibrahim, additional, and Itzykson, Raphael, additional

Published
2019
Full Text
View/download PDF

14. Outcomes Following Second Allogenic Haematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of EBMT

Author

Nabergoj, Mitja, primary, Wang, Junfeng, primary, Robin, Marie, primary, Kröger, Nicolaus, primary, Angelucci, Emanuele, primary, Poire, Xavier, primary, Passweg, Jakob R., primary, Dreger, Peter, primary, Platzbecker, Uwe, primary, Robinson, Stephen, primary, Rambaldi, Alessandro, primary, Sengeloev, Henrik, primary, Bornhäuser, Martin, primary, Stelljes, Matthias, primary, Ciceri, Fabio, primary, Mayer, Jiri, primary, Ladetto, Marco, primary, de Wreede, Liesbeth C., primary, Koster, Linda, primary, Hayden, Patrick John, primary, Czerw, Tomasz, primary, Hernandez Boluda, Juan Carlos, primary, McLornan, Donal P., primary, Chalandon, Yves, primary, and Yakoub-Agha, Ibrahim, primary

Published
2019
Full Text
View/download PDF

15. Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Author

Ruggeri, Annalisa, primary, Mueller, Carlheinz, additional, de Wreede, Liesbeth C., additional, Wang, Junfeng, additional, Wieten, Lotte, additional, Vago, Luca, additional, Hoogenboom, Jorinde, additional, Socie, Gerard, additional, Niittyvuopio, Riitta, additional, Yakoub-Agha, Ibrahim, additional, Crawley, Charles R, additional, Tholouli, Eleni, additional, Bulabois, Claude-Eric, additional, Choi, Goda, additional, Forcade, Edouard, additional, Huynh, Anne, additional, Lenhoff, Stig, additional, Gandemer, Virginie, additional, Ciceri, Fabio, additional, Kröger, Nicolaus, additional, Leleu, Xavier, additional, Itälä-Remes, Maija, additional, Rocha, Vanderson, additional, Bonini, Chiara, additional, Chabannon, Christian, additional, and Fleischhauer, Katharina, additional

Published
2019
Full Text
View/download PDF

16. Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT

Author

Robin, Marie, primary, Wang, Junfeng, primary, Koster, Linda, primary, Beelen, Dietrich W., primary, Bornhäuser, Martin, primary, Kroeger, Nicolaus, primary, Platzbecker, Uwe, primary, Finke, Jürgen, primary, Ganser, Arnold, primary, Blaise, Didier, primary, Ciceri, Fabio, primary, Maertens, Johan, primary, Labussiere-Wallet, Helene, primary, Chevallier, Patrice, primary, Passweg, Jakob R., primary, Cornelissen, Jan J, primary, Milpied, Noel, primary, Charbonnier, Amandine, primary, Bonifazi, Francesca, primary, de Wreede, Liesbeth C., primary, Hayden, Patrick, primary, Scheid, Christoph, primary, and Yakoub-Agha, Ibrahim, primary

Published
2019
Full Text
View/download PDF

17. Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients - the Diadem Study from the Chronic Malignancies Working Party of the EBMT

Author

Waszczuk-Gajda, Anna, primary, Wang, Junfeng, additional, de Wreede, Liesbeth C., additional, Sirait, Tiarlan, additional, Ozkurt, Zubeyde Nur, additional, Snowden, John A, additional, Dreger, Peter, additional, Illés, Árpád, additional, Arat, Mutlu, additional, Bulabois, Claude-Eric, additional, Baurmann, Herrad, additional, Sever, Matjaz, additional, Basak, Grzegorz W, additional, Nikolousis, Manos, additional, Potter, Victoria, additional, Schroyens, Wilfried, additional, Gyan, Emmanuel, additional, Van Gorkom, Gwendolyn, additional, de la Serna, Javier, additional, Guffroy, Blandine, additional, Hayden, Patrick J, additional, Beksac, Meral, additional, Schönland, Stefan O., additional, and Yakoub-Agha, Ibrahim, additional

Published
2019
Full Text
View/download PDF

18. Classification of Donor KIR-Genotype Information to Predict Outcome after Unrelated Hematopoietic Stell Cell Transplantation: The Jury Is Still out

Author

Schetelig, Johannes, primary, Baldauf, Henning, additional, Massalski, Carolin, additional, Frank, Sandra, additional, Sauter, Jürgen, additional, Stelljes, Matthias, additional, Ayuk, Francis A., additional, Gerbitz, Armin, additional, Bethge, Wolfgang, additional, Bug, Gesine, additional, Klein, Stefan A, additional, Wendler, Sarah, additional, Heidenreich, Falk, additional, Luedemann, Julia, additional, Lange, Vinzenz, additional, de Wreede, Liesbeth C., additional, Fürst, Daniel, additional, Schmidt, Alexander H., additional, Kobbe, Guido, additional, Ottinger, Hellmut Dietmar, additional, Mueller, Carlheinz, additional, Beelen, Dietrich W., additional, Mytilineos, Joannis, additional, Fleischhauer, Katharina, additional, and Bornhäuser, Martin, additional

Published
2018
Full Text
View/download PDF

19. Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT

Author

Gran, Charlotte, primary, Wang, Junfeng, additional, Nahi, Hareth, additional, Koster, Linda, additional, Gahrton, Goesta, additional, Wolschke, Christine, additional, Einsele, Hermann, additional, Itälä-Remes, Maija, additional, Blaise, Didier, additional, Niederwieser, Dietger, additional, Meijer, Ellen, additional, Petersen, Eefke J., additional, de Wreede, Liesbeth C., additional, Ljungman, Per, additional, Bourhis, Jean-Henri, additional, Veelken, Hendrik, additional, Beelen, Dietrich W., additional, Stelljes, Matthias, additional, Gerbitz, Armin, additional, Ceballos, Patrice, additional, Finke, Jürgen, additional, Passweg, Jakob R., additional, Milpied, Noel-Jean, additional, Bornhäuser, Martin, additional, Yakoub-Agha, Ibrahim, additional, Schönland, Stefan, additional, Garderet, Laurent, additional, and Kroeger, Nicolaus, additional

Published
2018
Full Text
View/download PDF

20. Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation — a Phase I/II Study

Author

Roex, Marthe C.J., primary, Balen, Peter van, additional, Germeroth, Lothar, additional, Hageman, Lois, additional, van Egmond, Esther, additional, Veld, Sabrina A.J., additional, Hoogstraten, Conny, additional, van Liempt, Ellis, additional, Zwaginga, Jaap J., additional, de Wreede, Liesbeth C., additional, Einsele, Hermann, additional, Veelken, Hendrik, additional, Halkes, Constantijn J.M., additional, Jedema, Inge, additional, and Falkenburg, J.H. Frederik, additional

Published
2018
Full Text
View/download PDF

21. Patient Bone Marrow Chimerism at Time of Donor Lymphocyte Infusion Predicts Development of Graft Versus Host Disease

Author

Koster, Eva AS, primary, de Wreede, Liesbeth C., additional, Wallet-Malicka, Sylwia, additional, Bogers, Lisette, additional, Balen, Peter van, additional, Marijt, Waf, additional, Jedema, Inge, additional, Borne, Peter von dem, additional, Veelken, Hendrik, additional, Falkenburg, J.H. Frederik, additional, and Halkes, Constantijn J.M., additional

Published
2018
Full Text
View/download PDF

22. Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Author

Henoun Loukili, Noureddine, Gras, Luuk, Koster, Linda, Blaise, Didier, Gedde-Dahl, Tobias, Maertens, Johan, Peffault De Latour, Regis, Sengeloev, Henrik, Mielke, Stephan, Chevallier, Patrice, Passweg, Jakob R., Byrne, Jenny Louise, Salmenniemi, Urpu, Sirvent, Anne, Guyotat, Denis, Sica, Simona, de Wreede, Liesbeth C., Onida, Francesco, Scheid, Christoph, Gurnari, Carmelo, Drozd-Sokolowska, Joanna, Raj, Kavita, Robin, Marie, McLornan, Donal P, and Yakoub-Agha, Ibrahim

Abstract

Introduction

Published
2023
Full Text
View/download PDF

23. Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has No Impact on Patient Outcome after Hematopoietic Stem Cell Transplantation

Author

Schetelig, Johannes, Damm, Frederik, Günther, Ulf - Peter, Baldauf, Henning, Rave, Carina, Koster, Linda, Schöfl, Gerhard, Klussmeier, Anja, Menghrajani, Kamal, Bolton, Kelly L., Rücker-Braun, Elke, Heidenreich, Falk, Münn, Marie, Fuhrmann, Markus, Visco, Ilaria, Frick, Mareike, Hablesreiter, Raphael, Arends, Christopher Maximilian, de Wreede, Liesbeth C., Nesterenko, Olena, Stelljes, Matthias, Bug, Gesine, Schröder, Thomas, Moiseev, Ivan Sergeevich, Schoemans, Helene, Koenecke, Christian, Teipel, Raphael, von Bonin, Malte, Bullinger, Lars, Bornhäuser, Martin, van den Brink, Marcel R.M., Schmidt, Alexander H., Lange, Vinzenz, Peric, Zinaida, and Penack, Olaf

Abstract

Introduction. Clonal hematopoiesis (CH) has been associated with increased mortality mainly due to associations with cardiovascular diseases and hematologic cancer. Previous studies with predominantly related stem cell donors suggest that donor CH modulates graft-versus-host reactions and may augment graft-versus-leukemia effects after allogeneic hematopoietic cell transplantation (alloHCT). The impact of donor CH in the setting of unrelated alloHCT remains to be determined. To address this question, we initiated a joint study of the Transplant Complications Working Party of EBMT and DKMS.

Published
2023
Full Text
View/download PDF

24. Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT

Author

Pagliuca, Simona, Mooyaart, Jarl, Kröger, Nicolaus, Finke, Jürgen, Potter, Victoria, Dreger, Peter, Hilgendorf, Inken, Bethge, Wolfgang Andreas, Peffault De Latour, Regis, Rambaldi, Alessandro, Sengeloev, Henrik, Passweg, Jakob, Gedde-Dahl, Tobias, Burns, David, Orchard, Kim, Mielke, Stephan, Edinger, Matthias, Andreani, Marco, Crivello, Pietro, Merli, Pietro, Hoogenboom, Jorinde D., de Wreede, Liesbeth C., Chabannon, Christian, Kuball, Jurgen, Gurnari, Carmelo, Fleischhauer, Katharina, Ruggeri, Annalisa, and Lenz, Tobias

Abstract

In allogeneic hematopoietic cell transplantation (allo-HCT), alloreactive T-cell responses (graft versus leukemia - GvL and graft versus host disease - GvHD) are mediated by the interaction between recipient antigens and donor lymphocytes via human leukocyte antigen (HLA) molecules.

Published
2023
Full Text
View/download PDF

26. Family Mismatched Donor Transplantation for Myelofibrosis: A Retrospective Analysis of the EBMT Chronic Leukaemia Working Party

Author

Raj, Kavita, primary, Olavarria, Eduardo, additional, Eikema, Diderik-Jan, additional, de Wreede, Liesbeth C, additional, Koster, Linda, additional, van Lint, Maria Teresa, additional, Ciceri, Fabio, additional, Passweg, Jakob, additional, Schaap, Nicolaas PM, additional, Carlson, Kristina, additional, Blaise, Didier, additional, Santarone, Stella, additional, Vitek, Antonin, additional, Diez-Martin, Jose L., additional, McLornan, Donal, additional, Robin, Marie, additional, Chalandon, Yves, additional, and Kroeger, Nicolaus, additional

Published
2016
Full Text
View/download PDF

27. Allogeneic Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis (HLH) in Adults: A Retrospective Study of the Chronic Malignancies and Inborn Errors Working Parties (CMWP and IEWP) of the EBMT

Author

Machowicz, Rafal, primary, Suarez, Felipe, additional, Jedrzejczak, Wieslaw W, additional, Eikema, Dirk-Jan, additional, de Wreede, Liesbeth C, additional, Blok, Henric-Jan, additional, Isaksson, Cecilia, additional, Einsele, Hermann, additional, Poiré, Xavier, additional, Nikolousis, Manos, additional, Johansson, Jan-Erik, additional, Kobbe, Guido, additional, Zecca, Marco, additional, Arnold, Renate, additional, Diez-Martin, Jose L., additional, Schönland, Stefan, additional, Lankester, Arjan C, additional, Gennery, Andrew, additional, and Kroeger, Nicolaus, additional

Published
2016
Full Text
View/download PDF

28. Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Author

van Gelder, Michel, primary, Ziagkos, Dimitris, additional, de Wreede, Liesbeth C, additional, van Biezen, Anja, additional, Dreger, Peter, additional, Gramatzki, Martin, additional, Stelljes, Matthias, additional, Smedegaard Andersen, Niels, additional, Schaap, Nicolaas PM, additional, Vitek, Antonin, additional, Beelen, Dietrich, additional, Volin, Liisa, additional, Finke, Jürgen, additional, Passweg, Jakob R, additional, Ganser, Arnold, additional, Machaczka, Maciej J, additional, Delgado, Julio, additional, Krüger, William, additional, Faber, Edgar, additional, Socie, Gerard, additional, Jindra, Pavel, additional, Afanasyev, Boris V, additional, Theobald, Matthias, additional, Chalandon, Yves, additional, Henseler, Anja, additional, Schoenland, Stefan O., additional, Nicolaus, Kroger, additional, and Schetelig, Johannes, additional

Published
2016
Full Text
View/download PDF

29. Center Characteristics and Procedure-Related Factors Have an Impact on Outcomes of Allogeneic Transplantation for Patients with CLL: A Retrospective Analysis from the European Society for Blood and Marrow Transplantation (EBMT)

Author

Schetelig, Johannes, primary, de Wreede, Liesbeth C, additional, Andersen, Niels S., additional, Moreno, Carol, additional, van Gelder, Michel, additional, Vitek, Antonin, additional, Karas, Michal, additional, Michallet, Mauricette, additional, Machaczka, Maciej J, additional, Gramatzki, Martin, additional, Beelen, Dietrich W., additional, Finke, Jurgen, additional, Delgado, Julio, additional, Volin, Liisa, additional, Passweg, Jakob, additional, Dreger, Peter, additional, Schaap, Nicolaas PM, additional, Theobald, Matthias, additional, Henseler, Anja, additional, van Biezen, Anja, additional, Bornhaeuser, Martin, additional, Iacobella, Simona, additional, Putter, Hein, additional, Schönland, Stefen, additional, and Kröger, Nicolaus, additional

Published
2016
Full Text
View/download PDF

31. Outcomes Of Haematopoietic Stem Cell Transplantation (HSCT) for Severe Congenital Neutropenia (SCN): Preliminary Results

Author

Fioredda, Francesca, primary, de Wreede, Liesbeth C, additional, Calvillo, Michaela, additional, Gaspar, Bobby, additional, Aljurf, Mahmoud, additional, van Biezen, Anja, additional, Morreale, Giuseppe, additional, Peters, Christina, additional, Knoedler, Erica M, additional, Al-Seraihy, Amal, additional, Yesilipek, M. Akif, additional, Fisher, Alain, additional, Bierings, Marc, additional, Donadieu, Jean, additional, Ozturk, Gulyuz, additional, Bourge, Francoise, additional, Bordon, Victoria, additional, Smith, Owen, additional, Bacigalupo, Andrea, additional, Passweg, Jakob, additional, Socie, Gerard, additional, Shretzenmeier, Hubert, additional, Marsh, Judith, additional, and Dufour, Carlo, additional

Published
2013
Full Text
View/download PDF

33. Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT

Author

Cremers, Eline, primary, van Biezen, Anja, additional, de Wreede, Liesbeth C., additional, Scholten, Marijke, additional, Vitek, Antonin, additional, Finke, Jürgen, additional, Platzbecker, Uwe, additional, Beelen, Dietrich, additional, Schwerdtfeger, Rainer, additional, Volin, Liisa, additional, Harhalakis, Nikolaos, additional, Schattenberg, Anton, additional, Nagler, Arnon, additional, de Witte, Theo, additional, and Kröger, Nicolaus, additional

Published
2011
Full Text
View/download PDF

34. High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT) Has a Significant but Transient Impact on Quality of Life: Lessons From the Chronic Lymphocytic Leukemia (CLL) ASCT Study by the CLL Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Author

de Wreede, Liesbeth C., primary, Watson, Maggie, additional, Milligan, Donald, additional, Michallet, Mauricette, additional, Dreger, Peter, additional, van Os, Marleen, additional, Dearden, Claire E., additional, Cordonnier, Catherine, additional, Leporrier, Michel, additional, Koza, Vladimir, additional, Homewood, Janis, additional, Corront, Bernadette, additional, Baerlocher, Gabriela M., additional, Herr, Wolfgang, additional, Niederwieser, Dietger, additional, Sutton, Laurent, additional, de Witte, Theo M., additional, and Schetelig, Johannes, additional

Published
2011
Full Text
View/download PDF

35. Favorable Long-Term Outcomes after Allogeneic Transplantation for Elderly Patients with Myelodysplastic Syndromes: A Report from the Chronic Malignancies Working Party of EBMT

Author

Schetelig, Johannes, de Wreede, Liesbeth C, Van Gelder, Michel, Koster, Linda, Beelen, Dietrich W, Mufti, Ghulam, Niederwieser, Dietger, Socie, Gerard, Platzbecker, Uwe, Finke, Jürgen, Maertens, Johan, Vitek, Antonin, Sengeloev, Henrik, Stuhler, Gernot Hermann, Volin, Liisa, Ljungman, Per, Kanz, Lothar, Ganser, Arnold, Luft, Thomas, Kobbe, Guido, Arnold, Renate, Alessandrino, Emilio Paolo, Russell, Nigel H., Robin, Marie, and Nicolaus, Kroger

Abstract

Introduction:Communicating about the risk of mortality after allogeneic hematopoietic stem cell transplantation (HCT) is a challenging task for physicians. This is especially true for elderly patients with aggressive hematologic malignancies. Mortality after HCT may be split in three major parts, death after relapse, therapy-related mortality (including late complications of previous treatments of the hematologic malignancies) and background or general population mortality from causes unrelated to the treatment or disease. In the framework of the competing endpoints, relapse and non-relapse mortality, background mortality mainly determines the magnitude of non-relapse mortality. To estimate the size of the background mortality, the risk of an age-, sex-, country- and calendar year matched population can be used as approximation. This can be done with methods from relative survival analysis. By nature, background mortality increases among elderly patients. In order to study the size of background and excess mortality we analyzed mortality in a population of adult transplant recipients with myelodysplastic syndromes (MDS) because this indication is characterized by a high median age already at diagnosis and large numbers of transplanted patients.

Published
2017
Full Text
View/download PDF

36. Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party

Author

Schetelig, Johannes, Chevallier, Patrice, Van Gelder, Michel, Hoek, Jennifer, Hermine, Olivier, Chakraverty, Ronjon, Browne, Paul, Milpied, Noel, Malagola, Michele, Socie, Gerard, Delgado, Julio, Deconinck, Eric, Damaj, Gandhi, Cordonnier, Catherine, Beelen, Dietrich W, Nguyen, Stephanie, Nikolousis, Emmanouil, Brecht, Arne, Mayer, Jiri, Hunault, Mathilde, Bittenbring, Jörg Thomas, Thieblemont, Catherine, Leprêtre, Stéphane, de Wreede, Liesbeth C, Dreger, Peter, and Kröger, Nicolaus

Abstract

BACKGROUND:Numbers of patients with high-risk Chronic Lymphocytic Leukemia (CLL) who have failed Ibrutinib, Idelalisib or Venetoclax when they are referred for allogeneic hematopoietic stem cell transplantation (alloHCT) are increasing. No data is available on patients with CLL who were referred for alloHCT and were on Idelalisib prior to the start of the conditioning regimen. Therefore, we retrospectively analyzed registry data on patients with CLL who had been exposed to idelalisib prior to alloHCT.

Published
2017
Full Text
View/download PDF

37. Life Expectancy in Long-Term Survivors Transplanted for Myelofibrosis: A Registry Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Author

Robin, Marie, Eikema, Diderik-Jan, de Wreede, Liesbeth C, Christine, Wolschke, Schetelig, Johannes, Van Lint, Maria Teresa, Beelen, Dietrich W, Knelange, Nina Simone, Brecht, Arne, Niederwieser, Dietger W., Vitek, Antonin, Kanz, Lothar, Arnold, Renate, Finke, Jürgen, Volin, Liisa, Yakoub-Agha, Ibrahim, Nagler, Arnon, Einsele, Hermann, Poire, Xavier, Chevallier, Patrice, Holler, Ernst, Ljungman, Per, Robinson, Stephen, Radujkovic, Aleksandar, Chalandon, Yves, and Nicolaus, Kroger

Abstract

Background:myelofibrosis is a rare hematological malignancy which can be cured by hematopoietic stem cell transplant (HSCT) and many studies are showing that 3 to 5-year survival after HSCT is between 45 to 70% in relative standard condition (chronic phase disease, HLA matched donor). Relapse and transplant-related mortality are more frequent the first 2 years post HSCT. To optimize the long-term management of these patients, we raised the question of long-term outcome in patients surviving in remission at least 2 years after HSCT. Furthermore, that's a recurrent question from the patient to know if his life expectancy can reach the general population one many years after transplant.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results